Natural Product: NPC483617

Natural Product IDNPC483617
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
VIMYRMWXQWTCCQ-JLNKQSITSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey VIMYRMWXQWTCCQ-JLNKQSITSA-N
Standard InCHI InChI=1S/C27H37NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21-24-27(29)28-25-26-22-19-18-20-23-26/h3-4,6-7,9-10,12-13,15-16,18-20,22-23H,2,5,8,11,14,17,21,24-25H2,1H3,(H,28,29)/b4-3-,7-6-,10-9-,13-12-,16-15-
SMILES CC/C=CC/C=CC/C=CC/C=CC/C=CCCCC(=NCc1ccccc1)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   391.29 Volume:   463.05
?
Van der Waals volume.
Dense:   0.845 LogP:   6.658
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.131
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.99
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   15.0 Rigid Bonds:   12.0
TPSA:   32.59
?
Topological Polar Surface Area.
H-Bond Acceptor:   2.0
H-Bond Donor:   1.0 Rings:   1.0
Heavy Atoms:   2.0

MedChem Properties

QED Drug-Likeness Score:   0.139 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.167 Fsp3:   0.37
MCE-18:   5.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.683 Fluc inhibitor:   0.306
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.011
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.496
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.343 Promiscuous compounds:   0.058

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.949 MDCK Permeability:   -4.761
Pgp-inhibitor:   0.987 Pgp-substrate:   0.0
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.003
20% Bioavailability (F20%):   0.169 30% Bioavailability (F30%):   0.624
50% Bioavailability (F50%):   0.373

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.517 MRP1:   0.996
Plasma Protein Binding (PPB):   97.562% Volume Distribution (VD):   0.003
Fu: 2.366%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.008
OATP1B3 inhibitor:   0.262 BCRP inhibitor:   0.009
BSEP inhibitor:   0.999

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.89 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   1.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   1.0 CYP2D6-substrate:   0.977
CYP3A4-inhibitor:   0.237 CYP3A4-substrate:   1.0
CYP2B6-substrate:   1.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  6.572 Half-life (T1/2):  0.143

ADMET: Toxicity

hERG Blockers:  0.757 hERG Blockers (10um):  0.762
Human Hepatotoxicity (H-HT):  0.002 Drug-induced Liver Injury (DILI):  0.0
AMES Toxicity:  0.978 Rat Oral Acute Toxicity:  0.014
Maximum Recommended Daily Dose:  0.0 Skin Sensitization:  1.0
Carcinogencity:  0.0 Eye Corrosion:  1.0
Eye Irritation:  1.0 Respiratory Toxicity:  0.999
Drug-induced Neurotoxicity:  0.075 Ototoxicity:  0.002
Hematotoxicity:  0.0 Drug-induced Nephrotoxicity:  0.307
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.001
A549 Cytotoxicity:  0.017 Hek293 Cytotoxicity:  0.0
BCF:   2.156
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.197
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.242
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.093
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[12932133]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[23891163]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[24972328]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. PMID[33320645]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO18988 Lepidium meyenii Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT862 Individual protein Epoxide hydratase Homo sapiens IC50 = 111.0 nM PMID[33320645]
NPT21303 Single protein Epoxide hydratase Mus musculus IC50 = 43.0 nM PMID[33320645]
NPT5882 Individual protein Epoxide hydrolase 2 Rattus norvegicus IC50 = 29.0 nM PMID[33320645]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC483617 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9048 High Similarity NPC121872
0.881 High Similarity NPC483616
0.8182 Intermediate Similarity NPC209764
0.75 Intermediate Similarity NPC74936
0.75 Intermediate Similarity NPC159178
0.7059 Intermediate Similarity NPC483620
0.6512 Remote Similarity NPC471307
0.6512 Remote Similarity NPC78041
0.6512 Remote Similarity NPC141139
0.6481 Remote Similarity NPC160120
0.6296 Remote Similarity NPC483619
0.6 Remote Similarity NPC483622
0.5893 Remote Similarity NPC289330
0.5714 Remote Similarity NPC202613
0.5439 Remote Similarity NPC483621
0.537 Remote Similarity NPC483624
0.5357 Remote Similarity NPC53596
0.5357 Remote Similarity NPC471313

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC483617 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5192 Remote Similarity NPD6690 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data